META Stock Prediction and Forecast [META]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 15 Aug 2025, 03:23 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for META Stock Prediction and Forecast [META]](https://i.ytimg.com/vi/ntwWZgW891Y/hqdefault.jpg)
AI-generated source summary
The analysis evaluates META stock as a buy candidate with a score of 4.58. Since late July 2025, the stock has gained 1.12%, or 0.10% daily. It identifies an upward trend with a potential short-term selling opportunity near the top of the channel, around $794.03. A break above this level could signal a stronger increase. The 3-month forecast suggests an 18.66% rise, potentially reaching between $849.83 and $941.88. The 12-month outlook forecasts a 26.61% increase, projecting a price range of $683.98 to $1041.75. Trading volume fell on the last day, which has a medium risk profile, while the stock has 1.92% volatility. The first support level is identified as $773.44, while it expects META to open down -$1.30 on August 15th trading at $780.83. A stop-loss is suggested at $754.30 (-3.56%). The P/E ratio is 27.06.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
